Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke "ACTIsSIMA"

Active, not recruiting

Phase 2 Results N/A

Summary of Purpose

Controlled study of stereotactic, intracranial injection of SB623 cells in patients with fixed motor deficits from ischemic stroke

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 November 2017.

1 Jan 2016 15 May 2015 30 May 2019 30 Sep 2019 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts